Fonte: Advances in Biological Regulation. Unidade: ESALQ
Assuntos: NEOPLASIAS PANCREÁTICAS, QUIMIOTERAPIA, TERAPÊUTICA MÉDICA
ABNT
CANDIDO, Saverio et al. Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals. Advances in Biological Regulation, v. 72, p. 22-40, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jbior.2019.03.002. Acesso em: 19 nov. 2024.APA
Candido, S., Abrams, S. L., Steelman, L. S., Lertpiriyapong, K., Martelli, A. M., Cocco, L., et al. (2019). Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals. Advances in Biological Regulation, 72, 22-40. doi:10.1016/j.jbior.2019.03.002NLM
Candido S, Abrams SL, Steelman LS, Lertpiriyapong K, Martelli AM, Cocco L, Ratti S, Follo MY, Murata RM, Rosalen PL, Bueno-Silva B, Alencar SM de, Lombardi P, Mao W, Montalto G, Cervello M, Rakus D, Gizak A, Lin H-L, Libra M, Akula SM, McCubrey JA. Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals [Internet]. Advances in Biological Regulation. 2019 ; 72 22-40.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.jbior.2019.03.002Vancouver
Candido S, Abrams SL, Steelman LS, Lertpiriyapong K, Martelli AM, Cocco L, Ratti S, Follo MY, Murata RM, Rosalen PL, Bueno-Silva B, Alencar SM de, Lombardi P, Mao W, Montalto G, Cervello M, Rakus D, Gizak A, Lin H-L, Libra M, Akula SM, McCubrey JA. Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals [Internet]. Advances in Biological Regulation. 2019 ; 72 22-40.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.jbior.2019.03.002